Have you tried the prostate cancer risk checker? prostatecanceruk.org/risk-checker.h…

We're looking for interns! We’re recruiting up to four interns in machine learning and/or clinical research to help us develop the next generation of AI-powered software to find cancer early. lucidamedical.com

Signposting #HCPs & #CancerPatients to real-time info & contacts – across multiple languages, inside #Ukraine & throughout much of #Europe onco-help.org in English onko-help.org in Ukranian

Listen to our CEO, Dr Antony Rix, speak on the AI Medical Podcast presented by Dr Felix Beacher. Antony Rix #radtwitter #findcancerprecisely #prostatecancer #AI anchor.fm/medicalaipodca…

Watch Paul Sayer, Founder of Prost8, talk about his experience with #prostatecancer and the Prost8UK 1 in 8 campaign. youtu.be/fZkqhuz7dq0

Due to technical issues on our website we have extended the #ICIS2022 abstract deadline by one week. Please submit your #cancerimaging abstracts by Wednesday 8 June. Join us in Boston from 12-14 September: icimagingsociety.org.uk/index.cfm?task…

Our team is recruiting survey-participants ages 40-75 to help us develop a sexual quality-of-life questionnaire that will improve future prostate cancer patient care. Your contribution makes a difference.💙 Survey: redcap.link/Compass_Study Questions? Send to [email protected]

Exclusive new content on our Youtube channel! Enjoy this 'LI-RADS' webinar from Dr Heiken & Prof Lucidarme. See them both speak at #ICIS2022 "Cancer Imaging: An All-Inclusive Specialty' 12-14 September in #Boston, USA #radtwitter #LIRADS #cancerimaging youtu.be/LWIdmoWHyb8

One not to be missed, including sessions from The Royal Marsden NHS Foundation Trust @c_messiou and Dow-Mu Koh

Excellent! There is a slightly more detailed but similar version online on ProstateMatters prostatematters.co.uk/determining-su… All men should be able to make an informed choice.

At BBC for BBC Radio 4 Today interview on how we’re doing better with a safer, more accurate & less harmful pathway MRI, targeted biopsy and focal therapy Imperial Prostate Imperial Urology Surgery and Cancer Imperial College London Imperial NHS 💙 Prostate Cancer UK Time point:2:48. bbc.co.uk/sounds/play/m0…

Prostate cancer diagnosis just got easier with CE Mark Certification of Lucida Medical's New Al groundbreaking software. We are proud to announce that we have received Class Ilb CE certification for our Al-based prostate cancer detection software, Prostate Intelligence™ (Pi)™🧵

As we step into the heart of November, we're happy to support a cause close to our💙 We proudly stand with the global movement dedicated to raising awareness about prostate health. In our commitment to advancing patient care, we're excited to bring you Prostate Intelligence™ 🧵

Here's a not-so-fun fact: while #MRI is the gold standard for #ProstateCancer diagnosis, there's still a 12% miss rate. We can do better! Come see how we are harnessing the power of MRI + AI to improve outcomes at #RSNA23. Find us at booth 4862 by the #AI Showcase. See you there!

ICIS 2023 - Cancer Imaging: Current guidelines for best practice ‘On Demand’ Did you miss our 22nd meeting at the British Museum? Don't worry – we've got you covered! Packed with insights, innovations & the latest updates in cancer imaging: 1️⃣Day:£99 2️⃣Days:£160 3️⃣Days:£230

Earlier this year Macmillan Cancer Support invested in our pioneering new AI platform, Pi™, that aims to improve the speed & accuracy of prostate cancer tests. This great talk covers the role that charities can play in supporting start-ups via impact investment. vimeo.com/970620775/eb9c…

Call for abstracts for #RSNA24! Submission deadline: 7 August. More details here: bit.ly/3HviHHd We'll be exhibiting! Visit the Lucida Medical stand to see a demo of our software Pi™ (Prostate Intelligence™). #RSNA2024 #radtwitter

Excellent overview of prostate MRI reporting best practice by Benjamin Spilseth, Francesco Giganti Francesco Giganti & Silvia Chang, covering diagnosis, quality, recurrence, monitoring and treatment and new technologies like AI. doi.org/10.1007/s00261…

We asked Anwar Padhani to choose the most important practice breakthroughs in prostate cancer diagnosis in 2024. The below The Lancet Commission lists interventions to tackle the surge in cases and shift the case mix from advanced to earlier-stage disease: thelancet.com/journals/lance…

Dr Francesco Giganti presenting results of the PAIR-1 study at #ECR2025, that demonstrates that Pi™ (Prostate Intelligence™) matches MDT-supported radiologists in accurately detecting prostate cancer on MRI.